TLR4 and Sepsis: Thus, we strongly believe that in combination with the advances in miRNA delivery techniques, miR-let-7b will very soon be used to treat perilous human sepsis as well as the complications presented by the COVID-19 pandemic by regulating innate neutrophil function through modulation of the TLR4/NF-κB axis identified in this study.